Publish date:

Traders Look Ahead But Averages Haunted by Yesterday

Net IPOs fly as blue-chips stall on road to recovery. Greenspan on the horizon.

Investors wondering if

Friday's record-setting session was the end of the summer rally as we know it should still be wondering, and might even be worrying a bit.

Sure, it's encouraging that after yesterday's harsh selloff, the major equity indices were up for most of the morning. But following a day like

yesterday -- when the

Nasdaq Composite Index

suffered its fourth-largest point drop ever -- stocks are bound to have something of a bounce to them, regardless of whether the near-term future holds a new leg up or a repeat of last summer. And come lunchtime on Wall Street, the

Dow Jones Industrial Average

had taken a dip into the red while the Comp was off its early high.

Plus -- and this is a big plus -- market players are waiting for



Alan Greenspan's


testimony tomorrow morning. Given recent inflation-friendly economic data, most folks expect Greenspan's comments to be relatively

even-handed .

Gary Kaminsky, managing director of the asset management group at

Neuberger & Berman

, expects Thursday's G-SPAN to be relatively eventless -- as least as far as interest rates are concerned. "I don't think we'll get any indication either way, beyond the economy is growing and the world is stable. I don't think we'll get any indication of the next move, so we'll just continue to invest," he said.

"Yesterday's action was a trading story," Kaminsky continued. "And that had more to do with Monday's action and fears about a top of the market. That anniversary got into short-term traders' focus. It made for an interesting storyline." He referred to July 20, 1998, which

marked the Nasdaq's peak before an almost-30% late-summer plummet last year.

"There are two ways '99 is like '98," he added. "The market has been doing well for the last six months, and there was a feeling for profit-taking. But the interest-rate scenario is obviously different, and more importantly, we are not faced with an emerging-markets crisis. Unless there is a

Long-Term Capital Management

hiding somewhere, you can't compare the two

years. ... It was just a day-trader type thing."

Although many attributed yesterday's selling to growing concerns about the year 2000 and the strain it may put on the PC industry, Kaminsky said that was just an excuse. "Regardless of whatever happens,


(MSFT) - Get Microsoft Corporation (MSFT) Report

is always going to be cautious about the coming quarter, always. So why after 40 quarters, people would be worried beats me. I guess we have new investors that get involved with Microsoft every quarter. But, you know, in the second quarter of 2000, people will be blaming the 'post-2000' influences."

The Dow, meanwhile, was busy being influenced by the ongoing -- relentless, never-ending, evil, as some chart-compiling journalists might describe it -- earnings season. The blue-chip proxy lately was down 3.80 to 10,992, off an intraday high of 11,055.97.



(GT) - Get Goodyear Tire & Rubber Company Report

, down 4.5%, was getting punished for missing numbers;



, up 0.5%, was being moderately congratulated for beating estimates; and


(XON) - Get Intrexon Corporation Report

, down 1.5%, was getting lightly slapped for merely meeting expectations. Among the Dow leaders to the upside were



(on yesterday's list of most injured),


(KO) - Get Coca-Cola Company Report


United Technologies



The Nasdaq had been recovering, gliding as high as 2769.60, but was lately up 13.41 or 0.5%, to 2745.59. Broadcasting from Netland (which this week has garnered some enthusiasm from IPOs), Internet Sector

index was climbing nearly 16 to 609.53, below an earlier high of 617.73.

The broader

S&P 500

was up 1.56 to 1379 after trading as high as 1387 and as low as 1375. The small-cap

Russell 2000

was down 0.23 to 453.32.

Market internals were mixed on lukewarm volume. On the

New York Stock Exchange

, decliners were leading advancers 1,444 to 1,292 on 426.3 million shares. But the ups still had the downs in

Nasdaq Stock Market

activity by 1,829 to 1,764 on 580.5 million shares. New 52-week highs were outpacing new lows 33 to 29 on the Big Board and 70 to 21 on the Nasdaq.

Bonds, yesterday's salvation from the equity tempest, were giving back some gains. The 30-year Treasury was down 8/32 to 90 29/32, yielding 5.91%. (For more on the fixed-income market, see today's early

Bond Focus.)

Paul Rich, a trader at

BT Brokerage

, said today's trading won't provide any answers. "We're just lingering around here, hanging out, waiting for Humphrey-Hawkins," he said. Like Kaminsky, the trader doesn't expect to get any breakthrough news out of Greenspan's testimony. Rich went on to say he doesn't expect the

Federal Open Market Committee

TheStreet Recommends

to change rates at its late-August meeting.

As for Tuesday's sell-off, he said: "What a wonderful run-up we've had. Yes, it was a decent sell-off, but certainly not cause for any alarm. ... We had a whole bunch of earnings overshadowed by the momentum yesterday, and I think that just shows what a momentum market this is becoming. We have all these new players in this market with access to the Internet and third-market brokers. And there are just a whole new set of parameters -- it's pretty funky."

Wednesday's Midday Watchlist

By Thomas Lepri
Staff Reporter


Earnings estimates from First Call; new highs and lows on a closing basis unless otherwise specified. Earnings reported on a diluted basis unless otherwise specified.


Three Dow components reported second-quarter earnings today with varying success. Eastman Kodak was up 3/8 to 73 5/8 after posting hot earnings of $1.52 a share, topping the 11-analyst estimate by a penny and up from last year's $1.38. Goodyear Tire was scuttling down 2 9/16, or 4.5%, to 55 1/16 after it said it earned 41 cents a share, missing the seven-analyst call of 45 cents and down from the previous year's $1.25. And Exxon's second-quarter numbers were just right -- 49 cents a share, in line with the 20-analyst consensus and down from the year-ago 65 cents. But in-line earnings are not a warm bowl of porridge, and Exxon was lately off 1 3/16 to 76 3/4.

Mergers, acquisitions and joint ventures



was rocketing up 8 1/8, or 16.4%, to 59 9/16 after

Johnson & Johnson

(JNJ) - Get Johnson & Johnson (JNJ) Report

set plans to buy the biotech company for $4.9 billion in stock, or about $61 a Centocor share, based on yesterday's closing prices.

Fiber optic carrier

IXC Communications


was lately up 2 3/16, or 6%, to 38 7/16 on news

Cincinnati Bell


is buying it for about $3.2 billion, including assumed debt. Under terms of the deal, each share of IXC stock will be converted into 2.0976 shares of Cincinnati Bell stock.

Earnings/revenue reports and previews


(ALL) - Get Allstate Corporation Report

was losing 1 1/8 to 35 7/16 after posting second-quarter earnings of 75 cents a share, four cents below the 18-analyst view and up a penny from last year's figure.

Bristol-Myers Squibb

(BMY) - Get Bristol-Myers Squibb Company Report

was off 1 9/16 to 69 15/16 after it reported second-quarter earnings of 47 cents a share, in line with the 23-analyst estimate and up from the year-ago 41 cents.



was gaining 2 3/8 to 62 7/16 after posting second-quarter earnings of 27 cents, beating the 18-analyst estimate of 24 cents and up from the year-ago 18 cents.



was inching up 5/8 to 53 1/4 after it said it earned 37 cents a share in its second-quarter, beating the 23-analyst estimate of 36 cents and up from the year-ago 31 cents.

In other earnings news:

Offerings and stock actions

Art Technology


heads today's list of Net IPOs, lately advancing 7 5/8, or 63.5%, to 19 5/8 in its first day of trading, having been priced at $12 a share last night by lead underwriter

Hambrecht & Quist




, an online provider of business information, was lately up 15 1/16, or 107.5%, to 29 1/16 in its trading debut. Lead underwriter

J. P. Morgan

priced the stock last night at $14 a share, at the top of its pricing range.

Insight Communications


was up a relatively modest 6, or 25%, to 30 1/2 in its first day on the market. Lead underwriter

Donaldson Lufkin & Jenrette

priced Insight yesterday at $24.50 a share, above its expected range of $21-$23.


was surging 60, or 214.2%, to 88 after the IPO was priced by

Credit Suisse First Boston

at a whopping $28 a share, above its $24-$26 range.

Weatherford International

(WFT) - Get Weatherford International plc Report

was off a scant 1/2 to 35 15/16 after setting plans to spin off its oilfield drilling products division,

Grant Prideco

, to its shareholders.

Analyst actions

Boston Scientific

(BSX) - Get Boston Scientific Corporation Report

was sinking 3, or 6.6%, to 42 3/8 after

ABN Amro

downgraded it to hold from buy.

IDEC Pharmaceuticals


was plummeting 4 3/8, or 5.3%, to 77 5/8 after

Morgan Stanley Dean Witter

cut it to neutral from outperform.